- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
LifeLabs Offers Better Access to Canadian-Based Prenatal Screening Test
LifeLabs reported that expectant mothers all across Canada are taking advantage of improved access to a simple blood test.
LifeLabs reported that expectant mothers all across Canada are taking advantage of improved access to a simple blood test that can provide important information about their pregnancy, including if their baby is at risk for fetal problems and genetic conditions, at as early as nine weeks gestation.
According to the press release:
The Panorama Non-Invasive Prenatal Test (NIPT) is the most accurate prenatal test available and has been performed by LifeLabs Medical Laboratory Services (“LifeLabs”) at its genetics lab in Toronto since October 2015. LifeLabs is the first Canadian laboratory to perform NIPT in Canada, which can decrease the need for invasive tests like amniocentesis in many pregnancies.
Sue Paish President and CEO of LifeLabs commented:
Since beginning to offer the test in October, interest and uptake by healthcare professionals and their patients has been tremendous. In less than three months LifeLabs is now performing the pre-natal test for expectant mothers in all ten provinces. By conducting this test in Canada, Canadians have better access to the test and are receiving results faster. Our healthcare system is also realizing meaningful savings.
Click here to view the full press release.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.